House Committee on Energy and Commerce Chairmen Waxman and Stupak Request Study Data for Vytorin

WASHINGTON, Feb. 20, 2009--Chairman Waxman and Subcommittee on Oversight and Investigations Chairman Stupak wrote to Schering-Plough and Merck, the companies developing Vytorin, to request further information regarding two studies on the drug. The monitoring boards for the studies released their data to Schering-Plough and Merck before the conclusion of the studies upon the request of those companies.

Committee on Energy and Commerce
2125 Rayburn House Office Building
Washington, D.C. 20515
(202) 225-2927 
 
See attachment

Posted: February 2009


View comments

Hide
(web2)